Validation of a single-sample urinary C-peptide creatinine ratio as a reproducible alternative to serum C-peptide in patients with Type 2 diabetes.

No Thumbnail Available
Authors
Bowman, Pamela
McDonald, Timothy J.
Shields, Beverley
Knight, Bridget A.
Hattersley, Andrew T.
Journal
Diabetic medicine : a journal of the British Diabetic Association
Type
Comparative Study
Research Support, Non-U.S. Gov't
Validation Studies
Publisher
Wiley
Rights
Archived with thanks to Diabetic medicine : a journal of the British Diabetic Association
Serum C-peptide can be used in Type 2 diabetes as a measure of endogenous insulin secretion, but practicalities of collection limit its routine clinical use. Urine C-peptide creatinine ratio is a non-invasive alternative that is stable for at least 3 days at room temperature in boric acid preservative. We aimed to assess the utility of urine C-peptide creatinine ratio in individuals with Type 2 diabetes as an alternative to serum C-peptide.
Citation
Validation of a single-sample urinary C-peptide creatinine ratio as a reproducible alternative to serum C-peptide in patients with Type 2 diabetes. 2012, 29 (1):90-3 Diabet. Med.
Note
This article is freely available via Open Access. Click on the ‘Additional Link’ above to access the full-text from the publisher’s site.